Author

A.-A. Raymond

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Organism:human· 4 Assay:bulk RNA-seq· 2 Research Focus:cancer & tumor microenvironment· 2 Research Focus:cell signaling & trafficking· 2 Assay:proteomics· 2 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

J.-W. Dupuy· 4 shared V. Moreau· 3 shared C. Dantzer· 2 shared F. Saltel· 2 shared N. Dugot-Senant· 2 shared P. Bioulac-Sage· 2 shared A. Abou-Ammoud· 1 shared A. Ars· 1 shared

Activity by Year

2021-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

4 shared papersCancer Biology

J.-W. Dupuy

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Emerging role of oncogenic β-catenin in exosome biogenesis as a driver of immune escape in hepatocellular carcinoma

C. Dantzer, J. Vache, A. Brunel, I. Mahouche, A.-A. Raymond, J.-W. Dupuy, M. Petrel, P. Bioulac-Sage, D. Perrais, N. Dugot-Senant, M. Verdier-Sage, B. Bessette, C. Billottet, V. Moreau

This study shows that oncogenic β-catenin reduces exosome release in HCC, leading to immune escape by decreasing immune cell infiltration.

bioRxiv · Oct 24, 2023Cancer Biology

Loss of RND3/RHOE controls entosis through LAMP1 expression in hepatocellular carcinoma

S. Basbous, L. Dif, C. Dantzer, S. Di Tommaso, J.-W. Dupuy, P. Bioulac-Sage, A.-A. Raymond, C. Desdouets, F. Saltel, V. Moreau

The paper identifies Rnd3 loss as inducing entosis in hepatocellular carcinoma, with LAMP1 playing a key role in the process and correlating with metastatic potential.

bioRxiv · Sep 1, 2023 · PreprintCancer Biology

The E3 ubiquitin ligase FBXL6 controls the quality of newly synthesized mitochondrial ribosomal proteins

J. Lavie, C. Lalou, W. Mahouf, J.-W. Dupuy, A. Lacaule, A. Ars, D. Lacombe, A.-M. Duchene, A.-A. Raymond, H. R. Rezvani, P. Ngondo, G. Benard

This study identifies FBXL6 as a regulator of mitochondrial ribosomal protein quality during cytosolic translation, showing its role in preventing aggregation and maintaining mitochondrial function.

bioRxiv · Nov 1, 2022Cell Biology

Discoidin domain receptor 2 drives melanoma drug resistance through AXL-dependent phenotype switching

M. Sala, N. Allain, A. Jabouille, E. Henriet, A. Abou-Ammoud, A. Uguen, S. Di-Tommaso, D. Cyril, A.-A. Raymond, J.-W. Dupuy, E. Gerard, N. Dugot-Senant, B. Rousseau, J.-P. Merlio, A. Pham-Ledart, , F. Saltel

This study shows DDR2 drives melanoma drug resistance via AXL-dependent phenotype switching, suggesting DDR inhibition as a potential second-line treatment.

bioRxiv · Mar 26, 2021 · PreprintCancer Biology